Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple SclerosisNEJM 376:221-234,280, Hauser, S.L.,et al, 2017
Multiple Sclerosis-Quenching the Flames of InflammationLancet 378:1759-1760, , 2011